methylformamide has been researched along with Carcinoma, Epidermoid in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kahn, SB; Rajdev, L; Skeel, R; Tormey, D; Wadler, S; Weller, E; Wiernik, PH; Yu, ZF | 1 |
| Berman, ML; Blessing, JA; Hatch, KD; McGuire, WP | 1 |
| Forastiere, AA; Natale, RB; Schnur, G; Takasugi, BJ; Vogel, WC | 1 |
1 trial(s) available for methylformamide and Carcinoma, Epidermoid
| Article | Year |
|---|---|
N-Methylformamide in advanced squamous cancer of the uterine cervix: an Eastern Cooperative Oncology Group phase II trial.
Topics: Aged; Antineoplastic Agents; Carcinoma, Squamous Cell; Cell Differentiation; Drug Administration Schedule; Female; Formamides; Humans; Middle Aged; Survival Rate; Treatment Outcome; Uterine Cervical Neoplasms | 2001 |
2 other study(ies) available for methylformamide and Carcinoma, Epidermoid
| Article | Year |
|---|---|
Phase II study of N-methylformamide (N-MF) (NSC 3051) in patients with advanced squamous cancer of the cervix. A Gynecologic Oncology Group study.
Topics: Adult; Aged; Antineoplastic Agents; Carcinoma, Squamous Cell; Combined Modality Therapy; Drug Evaluation; Female; Formamides; Humans; Infusions, Intravenous; Middle Aged; Uterine Cervical Neoplasms | 1990 |
Phase II trial of N-methylformamide in advanced head and neck cancer.
Topics: Aged; Antineoplastic Agents; Carcinoma, Squamous Cell; Drug Evaluation; Female; Formamides; Head and Neck Neoplasms; Humans; Injections, Intravenous; Male; Middle Aged | 1987 |